Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, +26

Journal of Clinical Oncology

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Arlene Chan, Suzette Delaloge, Frankie A. Holmes, +27

The Lancet Oncology

Breast OncologyHealth SciencesMedicineClinical TrialsImmune Checkpoint Inhibitor +7

Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.

Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng, +16

Journal of Clinical Oncology

Her2-directed RegimensBreast OncologyOncologyBid PoMedicine +10

Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer

Robert G. Prosnitz, Bin Yao, Catherine L. Farrell, +2

International Journal of Radiation Oncology*Biology*Physics

Advanced HeadRadiation MedicineNeck CancerPretreatment AnemiaRadiation Therapy +9

Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs

Xin Chen, Ruojun Wang, Xinshu Zhao, +18

Carcinogenesis

Mesenchymal Stem CellsTumor BiologyOncogenic AgentMedicineStem Cells +12

Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma

Rundong Zhang, Lin Tian, Chen Lj, +13

Gene Therapy

Chemokine Gene TherapyMedicineImmunologyPathologyImmune Checkpoint Inhibitor +8

MiR-663 inhibits radiation-induced bystander effects by targeting<i>TGFB1</i>in a feedback mode

Wentao Hu, Shuai Xu, Bin Yao, +10

RNA Biology

Radiation EffectRadiation BiologyTumor BiologyTranscriptional RegulationRadiation Medicine +17

Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease

Xiaodong Shi, Kai Sun, Rui Hu, +9

Journal of Neuroscience

Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET).

Arlene Chan, Suzette Delaloge, Frankie A. Holmes, +16

Journal of Clinical Oncology

Breast OncologyCancer ManagementDistant DfsAdjuvant ChemotherapyPlacebo-controlled Trial +14

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Suzette Delaloge, David Cella, Ying-Xuan Ye, +24

Annals of Oncology